Fichtenbaum, C. J., Ribaudo, H. J., Leon-Cruz, J., Overton, E. T., Zanni, M. V., Malvestutto, C. D., … Grinspoon, S. K. (2021). Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis, 223(2), 352. https://doi.org/10.1093/infdis/jiaa594

Fichtenbaum, Carl J., Heather J. Ribaudo, Jorge Leon-Cruz, Edgar T. Overton, Markella V. Zanni, Carlos D. Malvestutto, Judith A. Aberg, et al. “Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.” J Infect Dis 223, no. 2 (February 3, 2021): 352. https://doi.org/10.1093/infdis/jiaa594.

Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, et al. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2021 Feb 3;223(2):352.

Fichtenbaum, Carl J., et al. “Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.” J Infect Dis, vol. 223, no. 2, Feb. 2021, p. 352. Pubmed, doi:10.1093/infdis/jiaa594.

Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2021 Feb 3;223(2):352.